Anke Richter

Summary

Affiliation: RTI International
Country: USA

Publications

  1. ncbi A Monte Carlo simulation for modelling outcomes of AIDS treatment regimens
    Anke Richter
    RTI Health Solutions, Research Triangle Park, North Carolina 27709, USA
    Pharmacoeconomics 20:215-24. 2002
  2. ncbi The impact of reducing dose frequency on health outcomes
    Anke Richter
    RTI Health Solutions, Research Triangle Park, North Carolina 27709, USA
    Clin Ther 25:2307-35; discussion 2306. 2003
  3. ncbi A linear programming model for allocating HIV prevention funds with state agencies: a pilot study
    Stephanie R Earnshaw
    RTI Health Solutions, RTI International, 3040 Cornwallis Road, Research Triangle Park, NC 27709, USA
    Health Care Manag Sci 10:239-52. 2007
  4. ncbi HIV antiretroviral treatment: early versus later
    Josephine Mauskopf
    RTI Health Solutions, Research Triangle Park, NC 27709, USA
    J Acquir Immune Defic Syndr 39:562-9. 2005
  5. ncbi Optimal allocation of resources across four interventions for type 2 diabetes
    Stephanie R Earnshaw
    RTI Health Solutions, RTI, 3040 Cornwallis Road, P.O. Box 12194, Research Triangle Park, NC 27709, USA
    Med Decis Making 22:S80-91. 2002
  6. ncbi An economic review of compliance with medication therapy in the treatment of schizophrenia
    Patricia Thieda
    RTI Health Solutions, RTI International, 3040 Cornwallis Road, PO Box 12194, Research Triangle Park, NC 27709, USA
    Psychiatr Serv 54:508-16. 2003
  7. ncbi Allocating HIV prevention resources: a tool for state and local decision making
    Anke Richter
    Naval Postgraduate School, Monterey, CA, United States
    Health Policy 87:342-9. 2008
  8. ncbi Health and economic impacts of an HIV intervention in out of treatment substance abusers: evidence from a dynamic model
    Anke Richter
    Defense Resource Management Institute, Naval Postgraduate School, 1522 Cunningham Rd, Code 64Rt, Monterey, CA 93943, USA
    Health Care Manag Sci 8:67-79. 2005
  9. ncbi Resource allocation for control of infectious diseases in multiple independent populations: beyond cost-effectiveness analysis
    Margaret L Brandeau
    Department of Management Science and Engineering, Stanford University, Terman Building, Stanford, CA 94305, USA
    J Health Econ 22:575-98. 2003
  10. ncbi Assessing the impact of global price interdependencies
    Anke Richter
    Naval Postgraduate School, Defense Resources Management Institute, Monterey, California 93943, USA
    Pharmacoeconomics 26:649-59. 2008

Detail Information

Publications10

  1. ncbi A Monte Carlo simulation for modelling outcomes of AIDS treatment regimens
    Anke Richter
    RTI Health Solutions, Research Triangle Park, North Carolina 27709, USA
    Pharmacoeconomics 20:215-24. 2002
    ..The model is flexible and permits adaptation to the changing treatment environment in HIV infection...
  2. ncbi The impact of reducing dose frequency on health outcomes
    Anke Richter
    RTI Health Solutions, Research Triangle Park, North Carolina 27709, USA
    Clin Ther 25:2307-35; discussion 2306. 2003
    ..Schedules may influence whether a patient stays on the prescribed therapy and, if so, the degree to which the regimen is followed. Both factors are important determinants of health outcomes and health care costs...
  3. ncbi A linear programming model for allocating HIV prevention funds with state agencies: a pilot study
    Stephanie R Earnshaw
    RTI Health Solutions, RTI International, 3040 Cornwallis Road, Research Triangle Park, NC 27709, USA
    Health Care Manag Sci 10:239-52. 2007
    ..We find that less efficient strategies, where 58% fewer infections are averted, result in significantly more equitable allocations. This tool serves as a guide for allocating funds for prevention activities...
  4. ncbi HIV antiretroviral treatment: early versus later
    Josephine Mauskopf
    RTI Health Solutions, Research Triangle Park, NC 27709, USA
    J Acquir Immune Defic Syndr 39:562-9. 2005
    ..This report uses a modeling approach to compare starting HAART at a mean CD4+ T-cell count greater than 350 cells/microL (early) versus less than 350 cells/microL but greater than 200 cells/microL (later)...
  5. ncbi Optimal allocation of resources across four interventions for type 2 diabetes
    Stephanie R Earnshaw
    RTI Health Solutions, RTI, 3040 Cornwallis Road, P.O. Box 12194, Research Triangle Park, NC 27709, USA
    Med Decis Making 22:S80-91. 2002
    ..CONCLUSIONS: A resource allocation model identifies trade-offs involved when imposing budget and equity constraints on care for individuals with newly diagnosed diabetes...
  6. ncbi An economic review of compliance with medication therapy in the treatment of schizophrenia
    Patricia Thieda
    RTI Health Solutions, RTI International, 3040 Cornwallis Road, PO Box 12194, Research Triangle Park, NC 27709, USA
    Psychiatr Serv 54:508-16. 2003
    ..The authors examined published economic evaluations of schizophrenia and antipsychotic therapies to determine the role of compliance with medication therapy in the economic cost of schizophrenia...
  7. ncbi Allocating HIV prevention resources: a tool for state and local decision making
    Anke Richter
    Naval Postgraduate School, Monterey, CA, United States
    Health Policy 87:342-9. 2008
    ..By quantifying the impact of policy choices in terms of efficiency, cost, and distribution, the resource allocation tool makes the decision process more transparent and permits more informed choices...
  8. ncbi Health and economic impacts of an HIV intervention in out of treatment substance abusers: evidence from a dynamic model
    Anke Richter
    Defense Resource Management Institute, Naval Postgraduate School, 1522 Cunningham Rd, Code 64Rt, Monterey, CA 93943, USA
    Health Care Manag Sci 8:67-79. 2005
    ..A community-based intervention program found that the high-risk target population interacts with its surrounding community as a source of drugs and prostitution, creating a measure of co-dependence in the health status of each group...
  9. ncbi Resource allocation for control of infectious diseases in multiple independent populations: beyond cost-effectiveness analysis
    Margaret L Brandeau
    Department of Management Science and Engineering, Stanford University, Terman Building, Stanford, CA 94305, USA
    J Health Econ 22:575-98. 2003
    ..g. infection prevalence and incidence), the length of the time horizon, and prevention program characteristics. We establish conditions that characterize the optimal solution in certain cases...
  10. ncbi Assessing the impact of global price interdependencies
    Anke Richter
    Naval Postgraduate School, Defense Resources Management Institute, Monterey, California 93943, USA
    Pharmacoeconomics 26:649-59. 2008
    ..Understanding the behaviour of the pharmaceutical firm in this global context aids countries in designing policies to maximize the welfare of their citizens...